Browse studies

Find your next paid study

3 recruiting studies matching your filters

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma Across the Military Healthcare System

The goal of this observational cohort study is to learn how toxin and occupational exposures, germline genetic variation, and immune dysregulation relate to B-…

Non-Hodgkin LymphomaLymphoma Non-HodgkinB-cell Lymphoma+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Henry M. Jackson Foundation for the Advancement of Military MedicineNCT07652580

Phase 1

A Phase 1/2, Open-label, Multicenter Study of UB-VV400 With Rapamycin in Relapsed or Refractory B-cell Malignancies

This study is a Phase 1/2 dose-finding and dose-confirmation study to evaluate the safety and antitumor activity of UB-VV400. The study will enroll patients wi…

Lymphoma, B CellLymphoma Non-HodgkinHigh Grade B Cell Lymphoma+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Umoja BiopharmaNCT07735533

Phase 2

Epcoritamab in Combination With R-CHOP Debulking in Newly Diagnosed Patients With Aggressive Non-Hodgkin Lymphoma (DLBCL)

A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggress…

Non-Hodgkin's B-cell LymphomaLymphoma Non-HodgkinDiffuse Large B-Cell Lymphoma (DLBCL)

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Carrie Ho, MDNCT07588698